User:Mr. Ibrahem/Hyoscyamine
Clinical data | |
---|---|
Trade names | Anaspaz, Levbid, Levsin, others |
Other names | Hyoscyamine sulfate, daturine, duboisine |
AHFS/Drugs.com | Monograph |
MedlinePlus | a684010 |
Pregnancy category |
|
Routes of administration | By mouth, injection |
Drug class | Antispasmodics (antimuscarinic)[1] |
Legal status | |
Legal status | |
Pharmacokinetic data | |
Bioavailability | 50% protein binding |
Metabolism | Hepatic |
Elimination half-life | 3–5 hrs. |
Excretion | Urine |
Identifiers | |
| |
Chemical and physical data | |
Formula | C17H23NO3 |
Molar mass | 289.375 g·mol−1 |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
Hyoscyamine, sold under the brand name Anaspaz among others, is a medication used to treat irritable bowel syndrome, decrease saliva production, and treat cholinesterase inhibitor toxicity.[1] Evidence for infant colic is poor.[1] It may be taken by mouth or given by injection.[1]
Side effects may include dry mouth, urinary retention, blurry vision, palpitations, headache, anxiety, sleepiness, rash, and poor coordination.[1] Other side effects may include psychosis and glaucoma.[1] It is an antispasmodics or the antimuscarinic type.[1]
Hyoscyamine was initially isolated in 1833 from henbane.[2] It is available as a generic medication under a number of brands.[3] In the United States 30 tablets of 0.125 mg costs less than 10 USD as of 2021.[3]
References[edit]
- ^ a b c d e f g h i "Hyoscyamine Monograph for Professionals". Drugs.com. Archived from the original on 24 November 2021. Retrieved 10 December 2021.
- ^ Anderson, Kenneth (25 July 2021). Strychnine & Gold (Part 2): Volume One Part Two of the Untold History of Addiction Treatment in the United States. Independently published. p. 321. ISBN 979-8-5380-3154-2. Archived from the original on 11 December 2021. Retrieved 10 December 2021.
- ^ a b "Hyoscyamine Prices and Hyoscyamine Coupons - GoodRx". GoodRx. Archived from the original on 23 April 2019. Retrieved 10 December 2021.